LCTX:NYSEAMERICAN
바이오타임
US$1.53
arrow_upward
+1.32%(+0.020) 1D
US$1.53
0.00% (0.00)
bedtime시간 외 거래
휴장: 5월 1일, 오후 4시 0분 0초 GMT-4 · USD
search
모든 종목 코드
1D
5D
1M
6M
YTD
1Y
5Y
최대
| 종목 코드 | 가격 | 변동 | 변동률(%) |
|---|
insights_autoLCTX의 주요 통계 생성 중...
시가
US$1.52
고가
US$1.55
저가
US$1.49
시가총액
3.81억
거래량
136.28만
52주 최고가
US$2.09
52주 최저가
US$0.43
EPS
-US$0.28
베타
1.79
유통 주식수
2.49억
직원 수
75
뉴스 기사
웹 소스 기반
프로필
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform, Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Wikipedia
바이오타임에 관한 정보